Anxiety FAQ

Anxiety is the body's response to a perceived threat. It involves activation of the sympathetic nervous system, which produces faster heart rate, tighter chest, faster breathing, and heightened alertness. Anxiety is a normal human experience that everyone has at some point. It becomes a clinical concern when it's persistent, out of proportion to the situation, and interferes with sleep, work, or relationships for more than a few weeks. The clinical conditions defined by sustained anxiety are called anxiety disorders, and they include generalized anxiety disorder, panic disorder, social anxiety disorder, and others. See the Conditions section for the full set of diagnoses.

Anxiety is an emotion everyone has. An anxiety disorder is a clinical condition where anxiety is sustained, out of proportion to current circumstances, and interferes with daily life for at least several weeks. The threshold between the two is functional. If anxiety is shaping sleep, work performance, relationships, or daily decisions in ways the person wouldn't choose, it has likely crossed into clinical territory. The Conditions section covers the specific diagnoses and how clinicians distinguish them.

Anxiety disorders are among the most common psychiatric conditions in the United States. According to the National Institute of Mental Health, roughly 19 percent of U.S. adults experience an anxiety disorder in any given year, and about 31 percent will at some point in their lifetime. Generalized anxiety disorder affects about 3 percent of adults annually. Panic disorder affects 2 to 3 percent. Social anxiety disorder affects about 7 percent. The conditions are common, treatable, and often under-recognized.

Specific phobias are technically the most common anxiety condition by lifetime prevalence, affecting roughly 8 to 12 percent of U.S. adults. Among the anxiety disorders that most often bring patients to clinical attention, generalized anxiety disorder, social anxiety disorder, and panic disorder are the three most commonly diagnosed. Generalized anxiety is often considered the default anxiety presentation because the worry generalizes across topics rather than attaching to a specific trigger.

There's a meaningful genetic component to anxiety disorders. First-degree relatives of someone with an anxiety disorder are about two to three times more likely to develop one themselves than people without that family history. The heritability for most anxiety disorders is estimated at 30 to 50 percent in twin studies, which means roughly a third to half of the variance is genetic. The rest reflects environmental factors, life experiences, and the interaction between the two. A genetic predisposition isn't a determination; many people with significant family history of anxiety never develop a clinical condition.

'Cured' is the wrong frame. Anxiety disorders are highly treatable, and most patients who engage with appropriate treatment experience substantial improvement. For some conditions, particularly specific phobias and panic disorder treated with exposure-based CBT, the outcomes are durable and the person often functions without ongoing treatment afterward. For others, particularly generalized anxiety disorder, the pattern is more chronic, with treatment producing meaningful reduction in symptoms while the underlying tendency toward worry remains present at a lower intensity. The right frame is 'treatable' rather than 'permanent' or 'curable.'

Anxiety produces a recognizable set of physical symptoms through the sympathetic nervous system. The most common are chest tightness, heart palpitations, faster breathing or shortness of breath, dizziness, nausea, muscle tension (often in the shoulders, jaw, and back), sweating, trembling, tingling in the hands or face, and difficulty sleeping. These symptoms aren't imagined. They're measurable physiological changes produced by adrenaline, cortisol, and the rest of the body's stress response. The Symptoms section covers each in plain language with what the body is doing during each.

Yes. Anxiety-related chest tightness is one of the most common reasons people in their twenties and thirties visit the emergency department with chest pain that turns out to be non-cardiac. The mechanism involves intercostal muscle tension and changes in breathing pattern during the stress response. The pain is real but doesn't originate from the heart. A first episode of unexplained chest pain still warrants medical evaluation. Once cardiac causes are ruled out, anxiety is one of the most common explanations. See the Chest tightness article.

Yes. The gut and brain communicate through the vagus nerve and the broader autonomic nervous system. During anxiety, blood flow shifts away from digestion toward large muscles, and gut motility changes within minutes. The result registers as nausea, often in the upper abdomen, and sometimes alongside loss of appetite or diarrhea. Many people with chronic anxiety also have irritable bowel syndrome, and the two conditions reinforce each other. See The anxiety nausea connection.

Yes, though the mechanism is usually not what people expect. Anxiety often produces hyperventilation, meaning breathing slightly faster and shallower than the body's metabolic need. This lowers blood carbon dioxide and produces a sensation of not getting enough air, even though oxygen levels are normal or above normal. The remedy is counterintuitive: slow the breath rather than try to take deeper breaths. Breathe in for four seconds, out for six or seven, for about two minutes. The chemistry usually normalizes within a few minutes. See Hyperventilation and the breathing pattern of anxiety.

A panic attack is a sudden surge of intense fear with physical symptoms that peak within about 10 minutes. Common features include a pounding heart, chest tightness, shortness of breath, dizziness, trembling, sweating, nausea, a sensation that the surroundings are unreal, and a strong sense that something terrible is about to happen. The attack feels like a medical emergency. It isn't. The body can't sustain a maximum stress response indefinitely, and most panic attacks resolve within 20 to 30 minutes regardless of what the person does during them. See Why panic attacks end the way they do.

Panic attack is a defined clinical term. Anxiety attack isn't. In practice, anxiety attack is the common term people use for what may or may not meet the clinical criteria for a panic attack. A panic attack is a specific event with a defined symptom cluster that peaks within 10 minutes. An anxiety attack is sometimes a panic attack, sometimes a longer high-anxiety period that doesn't fit the panic attack criteria, and sometimes another phenomenon entirely. The distinction matters for treatment because panic disorder has a specific evidence-based treatment path.

The sensation of impending doom is a recognized feature of panic attacks and severe anxiety episodes. It results from the same adrenaline surge that produces the physical symptoms. The brain registers the body's activation, scans for a threat to match it, and when it can't find one, often reaches for the most catastrophic interpretation available, including the possibility of death. The feeling is intense and feels accurate in the moment. It isn't predictive. People who feel they're dying during panic attacks routinely don't die from them, and the feeling tends to ease as the adrenaline clears.

Sustained anxiety is associated with several real medical consequences over time. Chronic activation of the stress response affects cardiovascular health, immune function, sleep quality, gut function, and inflammation. People with long-standing untreated anxiety have higher rates of cardiovascular events, irritable bowel syndrome, tension-type headaches, and chronic pain. Treating the anxiety often improves these downstream conditions. The relationship is bidirectional: chronic medical illness also makes anxiety more likely. The two aren't separate systems.

Anxiety disorders develop through a combination of genetic predisposition, brain chemistry, life experiences, and environmental stressors. There's no single cause. The biological substrate involves the amygdala (the brain's threat-detection center), the prefrontal cortex (which normally regulates the amygdala's response), and several neurotransmitter systems including serotonin, norepinephrine, and GABA. People with anxiety disorders tend to have an oversensitive threat-detection system that reacts more strongly or more often than the situation calls for. Some of this is inherited. Some is shaped by stressful experiences, particularly during childhood. Some has no clear cause.

Stress and anxiety overlap but aren't the same. Stress is the body's response to a specific external demand and typically resolves when the demand ends. Anxiety is sustained worry, often without a clear current trigger, that involves the same physiological activation but doesn't turn off when the immediate situation does. Chronic stress is a risk factor for developing an anxiety disorder. Many people develop their first clinical anxiety episode after a period of sustained stress, and the activation that started as stress becomes self-sustaining. The relationship is bidirectional: anxiety also makes ordinary stress harder to recover from.

Trauma is a common precipitant of anxiety, particularly post-traumatic stress disorder, which is now in its own DSM-5-TR chapter but clinically overlaps with the anxiety conditions. Childhood adversity, including emotional neglect, abuse, family instability, and chronic illness, is associated with higher rates of anxiety disorders in adulthood. Not all anxiety is trauma-related, and many people develop anxiety without an identifiable trauma history. When trauma is present, it shapes the treatment approach: trauma-focused therapies like EMDR and prolonged exposure are often appropriate alongside or instead of standard anxiety treatments.

Yes. Several common medications can cause or worsen anxiety as a side effect. The most common offenders are stimulants (including caffeine, ADHD medications, and decongestants like pseudoephedrine), corticosteroids (prednisone is a particularly common trigger), thyroid medications when the dose is too high, some asthma medications (albuterol), and some antidepressants in the first one to two weeks of treatment. Anxiety that begins or worsens shortly after starting a new medication deserves a conversation with the prescribing clinician. The fix is often a dose adjustment or a switch to an alternative.

Yes. Several medical conditions produce symptoms that mimic anxiety: hyperthyroidism (often presents as restlessness, palpitations, weight loss, and heat intolerance), cardiac arrhythmias, low blood sugar in diabetics, anemia, pheochromocytoma (a rare adrenal tumor), and certain hormone imbalances. New-onset anxiety in someone without a prior history, particularly after age 40, deserves a basic medical workup to rule out these conditions. Anxiety that doesn't respond to standard treatment may also warrant medical re-evaluation.

A clinical evaluation is appropriate when anxiety has been interfering with sleep, work, or relationships for more than two to three weeks, when panic attacks are recurring, when avoidance behaviors are narrowing daily life, or when thoughts of self-harm appear. You don't need to be in crisis to seek help. Most people who eventually receive an anxiety diagnosis have been managing symptoms on their own for months or years before seeing a clinician. Earlier evaluation generally produces faster improvement. See Just diagnosed with anxiety: what happens next.

The threshold is functional. If anxiety is shaping your sleep, your work, your relationships, or your daily decisions in ways you wouldn't choose, it's bad enough to warrant a conversation with a clinician. Many patients arrive at first visits saying 'I'm not sure it's bad enough.' A useful reframe: the goal isn't to suffer until things are obviously falling apart. The goal is to feel like yourself, with the energy to do the things that matter to you. If you've been falling short of that for weeks, an evaluation is reasonable.

Several types of clinicians treat anxiety. A psychiatrist is a physician who can diagnose anxiety disorders and prescribe medication. A psychologist or therapist can diagnose anxiety and provide therapy, including CBT, but can't prescribe in most states. A primary care physician can often diagnose and start treatment for straightforward anxiety, and many patients begin treatment through their PCP and never need a specialist. For more complex cases, treatment resistance, or co-occurring conditions, a psychiatrist or a therapist with specific anxiety expertise is usually the right next step. See Finding psychiatric care.

Yes. Primary care physicians treat the majority of anxiety in the United States. A PCP can perform an initial evaluation, prescribe first-line medications like SSRIs, refer for therapy, and follow patients over time. For patients with straightforward anxiety, this is often the right level of care. For patients with treatment-resistant symptoms, complex co-occurring conditions (bipolar disorder, substance use, severe OCD), or who need specialized therapy (ERP for OCD, prolonged exposure for PTSD), referral to a psychiatrist or specialized therapist is usually appropriate.

Anxiety itself rarely requires emergency care. The exceptions are thoughts of suicide or self-harm with intent, severe chest pain that hasn't yet been evaluated to rule out cardiac causes, severe shortness of breath, fainting, or symptoms unusual enough that you can't tell whether it's anxiety or something medical. When uncertain, an emergency department evaluation is the right call. For thoughts of suicide, call or text 988 in the United States. For any immediate medical or safety emergency, call 911.

Anxiety is diagnosed clinically, through a conversation between a clinician and the patient. The clinician asks about symptoms, duration, severity, impact on daily life, family history, medical history, medication use, and substance use. Validated screening tools like the GAD-7 help quantify severity but don't replace the clinical interview. The DSM-5-TR provides specific diagnostic criteria for each anxiety disorder, including symptom requirements, duration thresholds, and functional impairment criteria. There's no blood test, brain scan, or biomarker that confirms an anxiety diagnosis.

No. There's no blood test, urine test, brain scan, or genetic test that can diagnose anxiety. Clinicians sometimes order blood tests to rule out medical conditions that mimic anxiety, including thyroid disease, cardiac arrhythmias, anemia, vitamin B12 deficiency, and certain hormone imbalances. These are exclusionary tests, not diagnostic tests for anxiety itself. The diagnosis comes from the clinical interview.

Self-recognition of symptoms is useful for deciding to seek evaluation, but self-diagnosis isn't the same as clinical diagnosis. Many anxiety symptoms overlap with other conditions, including depression, ADHD, thyroid disease, cardiac arrhythmias, and medication side effects. A clinical evaluation distinguishes among them in ways that matter for treatment. If you recognize yourself in the descriptions on this site, that's a reasonable signal to talk with a clinician, not a conclusion that bypasses one.

The two interventions with the strongest evidence are cognitive behavioral therapy and SSRI or SNRI medication. CBT is the most-studied psychological treatment and produces durable results, particularly when an exposure component is included. SSRIs (like sertraline and escitalopram) are first-line medications for most anxiety disorders. Either alone helps most patients. Combined treatment, CBT plus medication, tends to work faster for moderate-to-severe anxiety. The best treatment depends on the specific diagnosis, the severity, the patient's preferences, and what has worked previously. See How CBT and SSRIs actually work for anxiety.

Yes. Cognitive behavioral therapy alone is effective for many patients with mild to moderate anxiety. Behavioral changes (sleep, exercise, caffeine reduction, alcohol moderation) often produce substantial improvement. Some patients respond well to mindfulness-based therapies or acceptance and commitment therapy. For severe anxiety, treatment-resistant symptoms, or co-occurring depression, medication often improves outcomes meaningfully, but it's rarely the only option. The decision is made with a clinician based on severity, preferences, and previous response.

The timeline depends on the treatment. SSRIs typically take four to six weeks at a therapeutic dose to show clear effect. Most CBT protocols run 12 to 20 weekly sessions, with noticeable improvement often beginning in the first four to six weeks. Exposure therapy for specific phobias can be effective in as little as one to three sessions. Substantial improvement within three months is the typical pattern with appropriate treatment. For chronic anxiety, ongoing low-dose medication and periodic therapy tune-ups are common over years.

Not necessarily. For a first episode of anxiety that responds well to medication, a common approach is to continue treatment for 6 to 12 months past the point of meaningful improvement, then taper slowly under clinician guidance. For recurring anxiety or patients with multiple prior episodes, longer-term treatment is often appropriate. Some patients stay on a low maintenance dose for years; others stop entirely after the first treatment course. The decision is individual and made with a clinician over time. Tapering should always be gradual to avoid discontinuation symptoms.

Common, and usually fixable. The first SSRI doesn't work for everyone; a different SSRI or a different class often does. The first therapist isn't always the right match; switching is reasonable and not a failure. About 60 to 70 percent of patients respond well to the first SSRI tried; most non-responders respond to a second or third option. Most people who keep adjusting find a combination that works within several months. Treatment-resistant anxiety has multiple specialized options including augmentation strategies, combined approaches, and specialty referrals.

The most common medications for anxiety, in rough order of how often they're prescribed: SSRIs (sertraline, escitalopram, paroxetine, fluoxetine), SNRIs (venlafaxine, duloxetine), buspirone, benzodiazepines used cautiously and usually short-term, hydroxyzine (a sedating antihistamine for as-needed use), and beta-blockers (propranolol, for performance anxiety specifically). The Treatment, explained section covers each in detail.

No. SSRIs don't produce the cravings, escalation, or compulsive use that define addiction. They do produce physical adaptation, which means stopping them abruptly can cause discontinuation symptoms (dizziness, electric-shock sensations, irritability, flu-like feelings). The fix is to taper gradually under clinician guidance rather than stopping suddenly. Adaptation isn't addiction. Patients on SSRIs don't develop tolerance requiring higher doses, don't lose control over their use, and don't experience compulsive drug-seeking behavior.

Most SSRIs take four to six weeks at a therapeutic dose to show a clear effect on anxiety. Some patients notice change in the first one to two weeks; many don't. The first one to two weeks can include side effects (nausea, mild jitteriness, headaches, sleep changes, a temporary increase in anxiety) that usually settle. If a patient has been on a therapeutic dose for six weeks with no meaningful improvement, the dose or the specific medication is usually adjusted.

Xanax (alprazolam) is effective for acute anxiety but carries significant risks for long-term use, including physical dependence, withdrawal (which can be severe), rebound anxiety, cognitive effects, fall risk in older adults, and increased risk of fatal overdose when combined with opioids or alcohol. The FDA strengthened the boxed warning on benzodiazepines in 2020. Most current guidelines reserve benzodiazepines for short-term, time-limited use, often as a bridge while a longer-term treatment like an SSRI takes effect. They aren't first-line for chronic anxiety. See Benzodiazepines for anxiety.

Common side effects vary by class. SSRIs and SNRIs: nausea, jitteriness, headache, sleep changes, sexual side effects, and initial worsening of anxiety in the first one to two weeks (which usually settles). Benzodiazepines: sedation, cognitive slowing, fall risk, dependence with sustained use. Buspirone: dizziness, mild nausea, headache; often well-tolerated. Hydroxyzine: sedation, dry mouth. Beta-blockers: fatigue, slow heart rate, vivid dreams. Most side effects are manageable and many resolve within the first few weeks. The full picture for any specific medication is something to discuss with the prescribing clinician.

It depends on the medication. With SSRIs and SNRIs, light to moderate drinking is generally safe in patients without alcohol use disorder, though heavy drinking can worsen anxiety, interfere with sleep, and reduce medication effectiveness. With benzodiazepines, the combination is dangerous and can produce respiratory depression. With sedating medications like hydroxyzine, the sedation is additive. The honest answer for most anxiety patients: less alcohol is almost always better, and the anxiety-alcohol relationship is more consequential than most patients expect.

Cognitive behavioral therapy has the strongest evidence base. For panic disorder, CBT with an interoceptive exposure component is the gold standard. For OCD, exposure and response prevention (a specific form of CBT) is first-line. For PTSD, trauma-focused CBT or EMDR. For social anxiety, CBT with exposure. For generalized anxiety, CBT or acceptance and commitment therapy. Generic talk therapy helps with related life issues but produces weaker outcomes for anxiety symptoms themselves. The match between the specific anxiety condition and the therapy approach matters. See How CBT and SSRIs actually work and Exposure therapy, demystified.

Cognitive behavioral therapy is a structured, time-limited form of psychotherapy that focuses on the relationships between thoughts, feelings, and behaviors. For anxiety, CBT typically involves identifying anxious thought patterns, testing them against reality through behavioral experiments, and gradually approaching avoided situations through exposure. Most anxiety-focused CBT protocols run 12 to 20 weekly sessions. The therapy is active rather than passive; patients do homework between sessions. CBT has been studied more than any other psychotherapy and has the strongest evidence base for anxiety disorders.

The full process is covered in How to find a therapist for anxiety, but the short version: start with your insurance directory if you plan to use coverage, but expect it to be partly outdated. Cross-reference with the Psychology Today directory, the APA Psychologist Locator, the ABCT directory of CBT-trained therapists, and the IOCDF directory if OCD is part of the picture. Cast a wider net than you think you need; many therapists aren't accepting new patients. Out-of-network reimbursement is often more useful than people realize.

For most adult outpatient anxiety conditions, the published evidence supports telehealth therapy and telepsychiatry as comparable to in-person care for medication management and ongoing follow-up. Quality varies across platforms and individual clinicians. Continuity with the same clinician over time is one of the strongest predictors of outcome, which means platforms that reassign therapists frequently may produce weaker results than a stable telehealth arrangement with one provider.

Several practical changes reliably reduce anxiety symptoms over weeks. Protect sleep; aim for a consistent rise time and 7 to 8 hours. Reduce caffeine to under 200 mg per day. Reduce alcohol; even moderate drinking worsens anxiety the next day. Move regularly; 20 to 30 minutes of moderate exercise several times per week has good evidence. Spend time outside during daylight hours; morning light is particularly useful for sleep regulation. Limit doomscrolling and news consumption; the input matters. None of these replace clinical treatment for moderate-to-severe anxiety, but they improve the baseline that treatment works on.

Yes. Regular aerobic exercise produces measurable reductions in anxiety symptoms, with effect sizes comparable to some psychotherapies in meta-analyses. The mechanism likely involves changes in neurotransmitter systems, reductions in inflammation, improvements in sleep, and the behavioral activation of doing something rather than ruminating. The dose with the strongest evidence is 20 to 30 minutes of moderate aerobic activity (brisk walking, cycling, swimming) three to five times per week. Intensity matters less than consistency. Exercise isn't a substitute for treatment in moderate-to-severe anxiety, but it improves outcomes when added to standard care.

Structured mindfulness-based programs (MBSR, MBCT) have moderate evidence for anxiety, with effect sizes similar to other psychotherapies. The evidence base is built on 8-week structured programs taught by trained instructors, not on app-based meditation alone. Apps (Headspace, Calm, Insight Timer) are reasonable introductions and useful for maintenance, but as primary treatment for clinical anxiety, structured programs produce better outcomes.

The evidence is mixed and generally weaker than for prescription medications. Some compounds with modest evidence include passionflower, valerian (mostly studied for sleep), L-theanine, and ashwagandha. Magnesium has good evidence for muscle tension and sleep when deficiency is present, weaker evidence for anxiety in non-deficient individuals. CBD has growing but inconsistent evidence. Kava has been studied for anxiety but carries hepatotoxicity risk and is generally avoided. Supplements aren't regulated like medications, so quality and dosing vary substantially between products. For mild anxiety, some supplements are reasonable adjuncts; for moderate-to-severe anxiety, they aren't adequate substitutes for evidence-based treatment.

The evidence for CBD is preliminary and inconsistent. A few small clinical trials suggest CBD at moderate doses may reduce acute anxiety in performance contexts; the evidence for chronic anxiety is weaker. Quality control across CBD products is unreliable, with many products containing different amounts than labeled. The drug-interaction profile isn't yet well-characterized. For mild anxiety in selected patients, a trial of a reputable product isn't unreasonable; for moderate-to-severe anxiety, CBD shouldn't replace evidence-based treatment.

Caffeine can worsen anxiety in sensitive individuals, particularly at doses above 400 mg per day or in slow metabolizers. The mechanism involves adenosine receptor antagonism and increased norepinephrine release, which produces the physiological signs of activation that overlap with anxiety symptoms. Patients with panic disorder are particularly caffeine-sensitive. A two-week trial of caffeine reduction to under 200 mg per day often produces noticeable improvement in anxiety and sleep.

Acutely, alcohol reduces anxiety through GABA enhancement, producing brief relief. Over hours and days, alcohol consistently worsens anxiety. The morning after drinking, anxiety is reliably higher than baseline because of rebound activation. Sustained daily drinking shifts the brain's baseline toward higher activation, worsening anxiety during sober hours. The cycle is one of the most common patterns in adult psychiatry. The honest framing: short-term relief at the cost of long-term worsening. See Anxiety and alcohol use.

Diet has modest but real effects on anxiety. The two food-related variables with the strongest evidence are caffeine and alcohol, both covered above. Blood-sugar stability matters for some patients; large blood-sugar dips can produce anxiety-like symptoms. Mediterranean-style diets are associated with lower rates of depression and anxiety in observational studies, though the causal direction is unclear. Highly processed foods and high added-sugar intake are associated with worse mental health outcomes. Diet is unlikely to be the primary lever for severe anxiety, but it's a reasonable secondary one.

Several factors converge. Decreased external distraction means worries become more prominent. Body temperature and cortisol both drop in the evening, which can produce restlessness in anxious nervous systems. Lying still in a dark room increases interoceptive awareness of physical symptoms. Sleep onset requires a degree of nervous system quieting that anxious activation prevents. The pattern is so common it has a name: anxiety-related insomnia. See Anxiety insomnia and the 3 a.m. wake-up.

Cortisol naturally peaks in the morning, particularly in the first 30 to 45 minutes after waking (the cortisol awakening response). In anxious individuals, this peak is often higher and shifts earlier, producing wakings between 3 and 5 a.m. with the body already activated. Anticipatory worry about the day's demands amplifies the effect. Morning anxiety is a recognized clinical pattern, particularly in generalized anxiety disorder and anxious depression.

Anxiety is often a chronic condition with periods of higher and lower symptom intensity. Many patients experience meaningful improvement with treatment, then notice symptoms returning during periods of stress, sleep loss, illness, or major life transitions. The recurrence isn't a failure of previous treatment. It's the natural course of the condition for many people. The skills built during initial treatment usually still work; sometimes a brief return to therapy or medication adjustment is enough to restabilize.

For situational anxiety tied to a specific stressor, often yes. Once the stressor resolves, the anxiety settles. For clinical anxiety disorders, spontaneous remission is less common. Without treatment, most anxiety disorders persist or worsen over months and years. Treatment is the most reliable path to durable improvement. The decision to seek treatment is reasonable as soon as anxiety is interfering with daily life; waiting for it to resolve on its own is often a long wait.

Sunday-night anxiety is a recognizable pattern of anticipatory dread before the workweek begins. The mechanism involves anticipatory cognitive activation, decreased weekend structure, and the contrast between weekend recovery and Monday demands. For most adults, it's a time-limited response that fades after the week starts. When it intensifies into physical symptoms (chest tightness, sleep disruption, nausea) and persists across most Sundays for weeks, it's moving toward clinically significant anxiety and a clinical evaluation makes sense.

Premenstrual hormonal changes affect anxiety in many menstruating people, with symptoms typically intensifying in the week before menstruation and easing once it begins. In some patients, the pattern is severe enough to meet criteria for premenstrual dysphoric disorder (PMDD), which has its own treatment considerations including SSRIs dosed continuously or only during the luteal phase. Tracking symptoms across cycles helps confirm the pattern and clarify whether premenstrual exacerbation of an underlying anxiety disorder or PMDD is the better framing.

The most useful behaviors: take their experience seriously without panicking yourself, learn about their specific condition so you understand what they're dealing with, support their treatment (encourage them to keep appointments, take medication if prescribed), respect their pace of recovery, and avoid trying to fix them through advice they didn't ask for. Don't promise outcomes you can't guarantee. Don't minimize. Don't assume their experience matches yours. The full guide is at Supporting a partner or family member with anxiety.

Stay calm. Keep your voice steady. Acknowledge what's happening: 'You're having a panic attack. This will pass.' Don't try to talk them out of the panic. Offer a simple grounding action: a glass of cold water, slow breathing together, naming three things they can see. Stay with them. Most panic attacks resolve within 20 to 30 minutes; your job is to be present, not to cure it. If symptoms are unusual for them, suggest medical evaluation afterward.

Avoid: 'Just relax.' 'It's all in your head.' 'You're being dramatic.' 'Have you tried meditation?' (when they have). 'I had anxiety once and exercise fixed it.' 'What do you have to be anxious about?' These responses minimize the experience and reflect a misunderstanding of what anxiety is. Even well-intentioned, they tend to make people with anxiety feel more isolated. A more useful default is to ask what would help, listen, and resist the urge to fix.

Yes. Anxiety disorders are common in children and adolescents, with roughly 32 percent of teens experiencing an anxiety disorder at some point. Presentation varies by age: separation anxiety in younger children, social anxiety emerging around 13, generalized worry across ages. School refusal, somatic complaints (stomachaches, headaches with no clear cause), sleep disruption, and behavioral changes are common signals. Treatment is highly effective, with CBT and selected SSRIs as first-line options. See Pediatric anxiety.

No. Stress is the response to a specific external demand; it resolves when the demand ends. Anxiety is sustained worry, often without a clear current trigger, that involves the same physiological activation but doesn't turn off when the situation does. The two overlap, and chronic stress is a risk factor for developing an anxiety disorder, but they're different clinical phenomena with different treatment implications.

No. Anxiety disorders are clinical conditions with biological substrates involving specific brain circuits, neurotransmitter systems, and (in many cases) genetic predispositions. Having anxiety reflects a particular calibration of the threat-detection system, not a failure of willpower or moral character. The framing of anxiety as a personal failing is one of the most common reasons patients delay seeking treatment, and one of the most consequential misunderstandings to correct.

No. Anxiety disorders don't respond to willpower in the way the question implies. The underlying physiology, the sensitized threat-detection system, the activation of the autonomic nervous system, doesn't turn off through decision. Acute episodes do end on their own (panic attacks resolve within 30 minutes, anxiety surges within hours), but the underlying pattern requires treatment to change. The expectation that anxiety should be willed away is one of the more harmful cultural ideas in this space.

The phrase 'all in your head' usually implies the symptoms are imagined or not real. Anxiety symptoms aren't imagined. The chest tightness, heart palpitations, nausea, dizziness, and trembling are produced by real physiological processes (adrenaline release, sympathetic nervous system activation, changes in breathing pattern). The brain produces them, which is technically in the head, but they aren't less real for it. Dismissing anxiety symptoms as imagined is medically inaccurate and clinically harmful.

Cultural awareness of anxiety has increased, and more people are using anxiety vocabulary to describe their experiences than in previous decades. Whether this reflects true increases in clinical anxiety, better recognition of conditions that always existed, or a broader application of the word 'anxiety' to ordinary stress is debated in the literature. Both things are likely true: rates of clinical anxiety disorders have increased in some populations (particularly adolescents and young adults), and the casual use of the term has also expanded. The two patterns aren't the same and shouldn't be conflated.